Photo
October 19, 2018
Stratify Genomics launched its first product in September, a test called Prompt that screens users to determine their risk of developing prostate cancer.
Stories this photo appears in:
Stratify Genomics Uses Series A to Launch Prostate Cancer Screening Tool
San Diego startup Stratify Genomics wants to improve testing for prostate cancer by screening individuals to determine who is at a higher risk of developing it.
